The diagnosis, management, and best practices for treating infant lung diseases are the focus of this year’s Pediatric Core Curriculum at the ATS 2023 International Conference. The third and final session will take place on Wednesday, May 24, from 11 a.m.–noon ET in the West Salon G-I (Street Level) of the Walter E. Washington Convention Center.

Featured presentations include:

• Interstitial Lung Disease in Infants, Dima R. Ezmigna, MBBS, University of Florida
• Pulmonary Hypertension in Infants, Douglas Scott Bush, MD, Mount Sinai Health Systems

“These conditions [ILD and pulmonary hypertension] are rare, but it’s vital that providers are able to diagnose them early when patients present symptoms of these disorders,” said Pediatric Core Curriculum Chair Jane Gross, MD, PhD, a pediatric pulmonologist at National Jewish Health. “I think this is a great opportunity to get refreshed on these topics in a convenient, consolidated fashion.”

By the end of the three sessions of the Pediatric Core Curriculum, presenters also will have discussed best practices for the treatment of pulmonary hypertension in infants and the latest standards of care for the management of bronchopulmonary dysplasia in the neonatal ICU and the post-NICU period.

“This is a unique offering for the larger pediatric pulmonology community,” Dr. Gross said. “Each presentation is concisely designed to deliver evidence-based lessons in the management and diagnosis of various diseases while also helping professionals maintain the certifications and credentials required by their institutions.”

This session is worth one CME credit and one MOC point. CME certificates of credit/attendance will be awarded based on the participant attending the activity, submitting a completed evaluation, and attesting to the credits earned. A CME certificate will be available upon successful completion of all three components. For MOC points, participants must attend the session(s) and complete the corresponding evaluation and post-test for the activity with a passing score.

This session and the International Conference are supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests).